MEK inhibition by trametinib impairs the mobilization of monocytic MDSCs to facilitate anti-tumor T cell immunity
Publication
, Conference
Allegrezza, M; Svoronos, N; Perales-Puchalt, A; Payne, KK; Nguyen, J; Conejo-Garcia, JR
Published in: JOURNAL OF IMMUNOLOGY
2016
Duke Scholars
Published In
JOURNAL OF IMMUNOLOGY
EISSN
1550-6606
ISSN
0022-1767
Publication Date
2016
Volume
196
Related Subject Headings
- Immunology
- 3204 Immunology
- 3101 Biochemistry and cell biology
- 1107 Immunology
Citation
APA
Chicago
ICMJE
MLA
NLM
Allegrezza, M., Svoronos, N., Perales-Puchalt, A., Payne, K. K., Nguyen, J., & Conejo-Garcia, J. R. (2016). MEK inhibition by trametinib impairs the mobilization of monocytic MDSCs to facilitate anti-tumor T cell immunity. In JOURNAL OF IMMUNOLOGY (Vol. 196).
Allegrezza, Michael, Nikolaos Svoronos, Alfredo Perales-Puchalt, Kyle K. Payne, Jenny Nguyen, and Jose R. Conejo-Garcia. “MEK inhibition by trametinib impairs the mobilization of monocytic MDSCs to facilitate anti-tumor T cell immunity.” In JOURNAL OF IMMUNOLOGY, Vol. 196, 2016.
Allegrezza M, Svoronos N, Perales-Puchalt A, Payne KK, Nguyen J, Conejo-Garcia JR. MEK inhibition by trametinib impairs the mobilization of monocytic MDSCs to facilitate anti-tumor T cell immunity. In: JOURNAL OF IMMUNOLOGY. 2016.
Allegrezza, Michael, et al. “MEK inhibition by trametinib impairs the mobilization of monocytic MDSCs to facilitate anti-tumor T cell immunity.” JOURNAL OF IMMUNOLOGY, vol. 196, 2016.
Allegrezza M, Svoronos N, Perales-Puchalt A, Payne KK, Nguyen J, Conejo-Garcia JR. MEK inhibition by trametinib impairs the mobilization of monocytic MDSCs to facilitate anti-tumor T cell immunity. JOURNAL OF IMMUNOLOGY. 2016.
Published In
JOURNAL OF IMMUNOLOGY
EISSN
1550-6606
ISSN
0022-1767
Publication Date
2016
Volume
196
Related Subject Headings
- Immunology
- 3204 Immunology
- 3101 Biochemistry and cell biology
- 1107 Immunology